Medical Countermeasures New Insights Into Tularemia Pathogen May Inform Next-Generation Medical CountermeasuresGlobal Biodefense StaffMay 14, 2026
Research Scientists Identify Exact Trigger Behind Rare COVID Vaccine Blood ClotsGlobal Biodefense StaffFebruary 15, 2026
Infectious Diseases Last Flu Season Saw Highest U.S. Hospitalization Rates in Over a DecadeGlobal Biodefense StaffSeptember 24, 2025
The Case for a Seven-Gene-Deleted African Swine Fever Virus vs. Live Attenuated Vaccine Research March 5, 2020 …
Molecular and Serological Investigation of SARS-CoV-2: Implication of Multiple Shedding Routes Research February 28, 2020 …
U.S. Ebola Treatment Center Costs and Sustainability if Federal Funding Withdrawn Policy + Initiatives February 25, 2020 …
Tulane National Primate Research Center Launches Coronavirus Research Program Medical Countermeasures February 21, 2020 …
Columbia University Researchers Awarded $2 Million to Identify Antiviral Drugs for New Coronavirus Medical Countermeasures February 20, 2020 …
High-Throughput Automated Biodosimetry in Response to a Large-Scale Radiological Event CBRNE February 19, 2020 …
Persons Evaluated for 2019 Novel Coronavirus — United States, January 2020 Research February 14, 2020 …
The Lancet: Preliminary Evidence Suggest New Coronavirus Cannot Be Passed From Mother to Child Late in Pregnancy Pathogens February 13, 2020 …
First-Ever Therapeutic Antibody Cocktail for Sudan Virus Shows Promise in Animal Studies Medical Countermeasures February 4, 2020 …
A Pneumonia Outbreak Associated with a New Coronavirus of Probable Bat Origin Pathogens February 3, 2020 …
